Anke Unger

Otto Hahn Str. 15
Dortmund, NW 44227, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Targeting a Glutamic Acid in PDEδ with Fluoromethyl-Aryl Electrophiles Impairs K-Ras Signaling.

Targeting a Glutamic Acid in PDEδ with Fluoromethyl-Aryl Electrophiles Impairs K-Ras Signaling.

Journal: Journal of medicinal chemistry

Published: January 07, 2026

Design, Synthesis, and Structural Evolution of Pseudo-Natural Product IDO1 Inhibitors and Degraders.

Design, Synthesis, and Structural Evolution of Pseudo-Natural Product IDO1 Inhibitors and Degraders.

Journal: Angewandte Chemie (International ed. in English)

Published: August 26, 2025

Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors.

Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors.

Journal: Molecules (Basel, Switzerland)

Published: May 26, 2025

Design and Synthesis of Pyridine-Based Pyrrolo[2,3-d]pyrimidine Analogs as CSF1R Inhibitors: Molecular Hybridization and Scaffold Hopping Approach.

Design and Synthesis of Pyridine-Based Pyrrolo[2,3-d]pyrimidine Analogs as CSF1R Inhibitors: Molecular Hybridization and Scaffold Hopping Approach.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 29, 2025

Covalent modification of a glutamic acid inspired by HaloTag technology.

Covalent modification of a glutamic acid inspired by HaloTag technology.

Journal: Nature communications

Published: February 04, 2025

Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections.

Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections.

Journal: Cell host & microbe

Published: August 23, 2024

Pyrrolopyrimidine based CSF1R inhibitors: Attempted departure from Flatland.

Pyrrolopyrimidine based CSF1R inhibitors: Attempted departure from Flatland.

Journal: European journal of medicinal chemistry

Published: November 09, 2023

Synthesis and Development of Highly Selective Pyrrolo[2,3-d]pyrimidine CSF1R Inhibitors Targeting the Autoinhibited Form.

Synthesis and Development of Highly Selective Pyrrolo[2,3-d]pyrimidine CSF1R Inhibitors Targeting the Autoinhibited Form.

Journal: Journal of medicinal chemistry

Published: May 16, 2023

Discovery of tetrazolo-pyridazine-based small molecules as inhibitors of MACC1-driven cancer metastasis.

Discovery of tetrazolo-pyridazine-based small molecules as inhibitors of MACC1-driven cancer metastasis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 25, 2023

Protection of pancreatic islets from oxidative cell death by a peripherally-active morphinan with increased drug safety.

Protection of pancreatic islets from oxidative cell death by a peripherally-active morphinan with increased drug safety.

Journal: Molecular metabolism

Published: March 03, 2023

A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation.

A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation.

Journal: European journal of medicinal chemistry

Published: January 20, 2023

Inhibition of mammalian mtDNA transcription acts paradoxically to reverse diet-induced hepatosteatosis and obesity.

Inhibition of mammalian mtDNA transcription acts paradoxically to reverse diet-induced hepatosteatosis and obesity.

Journal: Nature metabolism

Published: November 03, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026